Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 DiabetesLARSEN, Claus M; FAULENBACH, Mirjam; VAAG, Allan et al.Diabetes care. 2009, Vol 32, Num 9, pp 1663-1668, issn 0149-5992, 6 p.Article

Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammationPALMER, Gaby; TALABOT-AYER, Dominique; KAYA, Gürkan et al.Journal of investigative dermatology. 2007, Vol 127, Num 8, pp 1938-1946, issn 0022-202X, 9 p.Article

Interleukin-1-receptor antagonist in type 2 diabetes mellitusLARSEN, Claus M; FAULENBACH, Mirjam; VAAG, Allan et al.The New England journal of medicine. 2007, Vol 356, Num 15, pp 1517-1526, issn 0028-4793, 10 p.Article

Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individualsCULLUP, H; MIDDLETON, P. G; DUGGAN, G et al.Clinical and experimental immunology (Print). 2004, Vol 137, Num 2, pp 351-358, issn 0009-9104, 8 p.Article

Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonistSHEPHERD, Joanna; LITTLE, Matthew C; NICKLIN, Martin J. H et al.Journal of investigative dermatology. 2004, Vol 122, Num 3, pp 665-669, issn 0022-202X, 5 p.Article

Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancerGLAS, Jürgen; TÖRÖK, Helga-Paula; SCHNEIDER, Agnes et al.Journal of clinical oncology. 2004, Vol 22, Num 23, pp 4694-4700, issn 0732-183X, 7 p.Article

Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonistMOLNAR, Clemens; GARCIA-TREVIJANO, Elena R; TILG, Herbert et al.European cytokine network (Montrouge). 2004, Vol 15, Num 4, pp 303-311, issn 1148-5493, 9 p.Article

Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue : ObesityJUGE-AUBRY, Cristiana E; SOMM, Emmanuel; CHICHEPORTICHE, Rachel et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 6, pp 2652-2658, issn 0021-972X, 7 p.Conference Paper

Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1β production by human monocytesFURSE, Robert K; ROSSETTI, Ronald G; SEILER, Christina M et al.Journal of clinical immunology. 2002, Vol 22, Num 2, pp 83-91, issn 0271-9142Article

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type Diabetes : The Whitehall II StudyHERDER, Christian; BRUNNER, Eric J; RATHMANN, Wolfgang et al.Diabetes care. 2009, Vol 32, Num 3, pp 421-423, issn 0149-5992, 3 p.Article

Association of C-Reactive Protein, Interleukin-1 Receptor Antagonist and Adiponectin with the Metabolic SyndromeSALTEVO, Juha; VANHALA, Mauno; KAUTIAINEN, Hannu et al.Mediators of inflammation. 2007, Vol 2007, Num 2, pp 1-8, issn 0962-9351, 8 p.Article

Counter-regulation of interleukin-1α (IL-1α) and IL-1 receptor antagonist in murine keratinocytesMEE, John B; ANTONOPOULOS, Christos; POOLE, Stephen et al.Journal of investigative dermatology. 2005, Vol 124, Num 6, pp 1267-1274, issn 0022-202X, 8 p.Article

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonistHOFFMAN, Hal M; ROSENGREN, Sanna; BOYLE, David L et al.Lancet (British edition). 2004, Vol 364, Num 9447, pp 1779-1785, issn 0140-6736, 7 p.Article

The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin α-amanitinGUNDALA, Sri; WELLS, Lisa D; MILLIANO, Michael T et al.Archives of toxicology. 2004, Vol 78, Num 2, pp 68-73, issn 0340-5761, 6 p.Article

Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsisARNALICH, F; LOPEZ-MADERUELO, D; CODOCEO, R et al.Clinical and experimental immunology (Print). 2002, Vol 127, Num 2, pp 331-336, issn 0009-9104Article

Polymorphism of IL-1 receptor antagonist gene: Role in cancerSEHOULI, Jalid; MUSTEA, Alexander; KÖNSGEN, Dominique et al.Anticancer research. 2002, Vol 22, Num 6A, pp 3421-3424, issn 0250-7005, 4 p.Article

Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid heamorrhageGUEORGUIEVA, Ivelina; CLARK, Simon R; MCMAHON, Catherine J et al.British journal of clinical pharmacology. 2008, Vol 65, Num 3, pp 317-325, issn 0306-5251, 9 p.Article

A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degenerationLE MAITRE, Christine L; FREEMONT, Anthony J; HOYLAND, Judith A et al.International journal of experimental pathology. 2006, Vol 87, Num 1, pp 17-28, issn 0959-9673, 12 p.Article

Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiencyUELAND, Thor; JØRGENSEN, Anders P; GODANG, Kristin et al.Clinical endocrinology (Oxford. Print). 2011, Vol 74, Num 1, pp 60-66, issn 0300-0664, 7 p.Article

Interleukin-1 Receptor Antagonist Enhances Islet Engraftment Without Impacting Serum Levels of Nitrite or OsteopontinHSU, B. R; FU, S.-H; HSU, S et al.Transplantation proceedings. 2009, Vol 41, Num 5, pp 1781-1785, issn 0041-1345, 5 p.Article

Anti-inflammatory effects of UV-irradiated lymphocytes : induction of IL-1Ra upon phagocytosis by monocyte/macrophagesCRACIUN, Ligia I; DIGIAMBATTISTA, Mario; SCHANDENE, Liliane et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 114, Num 3, pp 320-326, issn 1521-6616, 7 p.Article

Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndromeFOSTER, David C; SAZENSKI, Todd M; STODGELL, Christopher J et al.Journal of reproductive medicine. 2004, Vol 49, Num 7, pp 503-509, issn 0024-7758, 7 p.Article

Differential modulation of synthesis of human IL-1 beta and IL-1 receptor antagonist by cyclosporin ALUFFT, V; LINNEWEBER, S; LONNEMANN, G et al.Transplantation proceedings. 2002, Vol 34, Num 4, pp 1130-1132, issn 0041-1345Article

Decreased levels of peritoneal interleukin-1 receptor antagonist in patients with endometriosis and disease-related dysmenorrheaXINMEI ZHANG; JIE WEN; LIN DENG et al.Fertility and sterility. 2007, Vol 88, Num 3, pp 594-599, issn 0015-0282, 6 p.Article

Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitisBENSON, Mikael; WENNERGREN, Göran; FRANSSONA, Mattias et al.International archives of allergy and immunology. 2004, Vol 134, Num 3, pp 227-232, issn 1018-2438, 6 p.Article